Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Clinical Trials Administrator Archives – September 1, 2004

September 1, 2004

View Archives Issues

  • Navigate the labyrinth of Medicare reimbursement for clinical trials

    If there is any doubt in the minds of clinical trials administrators and coordinators about the complexity of Medicare and insurer reimbursement in clinical trials, then they need look no further than what happened when the National Academy of Sciences convened a task force to address the subject five years ago: Its main proposals never were adopted.
  • Clinical trials support office is a new trend

    One way an institution can promote research and provide support to clinical trials coordinators and investigators is through the formation of a clinical trials support office.
  • Guest Column

    Pharmaceutical companies conducting clinical trials in the United States tend to focus their regulatory attention solely on the requirements imposed by the FDA. This can be a mistake. Focusing on FDA regulations to the exclusion of state regulatory requirements may put the sponsor at risk. A large and increasing number of state requirements apply to clinical trials.
  • Software Update: Clinical trials software offered free of charge

    In this issue, Clinical Trials Administrator begins with this issue a periodic series on clinical trials software, looking at its use, potential, and availability. The software featured in this issue is eCTM, created by CyberMedica Foundation of Kennebunkport, ME.
  • Genetics emerging new frontier for drug trials 

    When the general public pictures genetic research, they think of new screening tests to detect rare diseases, or they think of cutting-edge gene therapy experiments that have the potential to completely reverse a previously fatal condition. However, the real promise of genetic knowledge, say many experts, is in the potential to target drug therapy for common diseases, such as heart disease and cancer, that affect huge numbers of people.
  • Audio conference: Including children in clinical research